Alangcas, Rufino S.

HRN: 02-36-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2026
CEFTRIAXONE 1G (VIAL)
04/26/2026
05/02/2026
IV
2 GM
OD
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: